ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 146 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,424 | -79.2% | 14,808 | -74.1% | 0.00% | – |
| Q2 2023 | $213,756 | -45.7% | 57,154 | -51.4% | 0.00% | – |
| Q1 2023 | $393,947 | +16.6% | 117,596 | +67.4% | 0.00% | – |
| Q4 2022 | $337,922 | +144.9% | 70,254 | +188.9% | 0.00% | – |
| Q3 2022 | $138,000 | +2.2% | 24,320 | +28.2% | 0.00% | – |
| Q2 2022 | $135,000 | -95.2% | 18,972 | -95.1% | 0.00% | – |
| Q1 2022 | $2,797,000 | -64.4% | 387,529 | -55.9% | 0.00% | -100.0% |
| Q4 2021 | $7,863,000 | +97.5% | 879,516 | +674.5% | 0.00% | +200.0% |
| Q3 2021 | $3,981,000 | +245.3% | 113,566 | +111.7% | 0.00% | – |
| Q2 2021 | $1,153,000 | – | 53,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |